Neuren Pharmaceuticals Ltd (NEU.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2003 | 12-2002 | |
| Cash Flows From Operating Activities | ||
| Operating Cash Flow | $N/A | $N/A |
| Cash Flows From Investing Activities | ||
| PPE Investments | -211 | -750 |
| Investing Cash Flow | $-211 | $-750 |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 576 | 8,480 |
| Financing Cash Flow | $576 | $8,480 |
| Exchange Rate Effect | -19 | -38 |
| Beginning Cash Position | 5,659 | 3,506 |
| End Cash Position | 1,326 | 6,010 |
| Net Cash Flow | $-4,314 | $2,542 |
| Free Cash Flow | ||
| Capital Expenditure | -211 | -750 |
| Free Cash Flow | -211 | -750 |